Top 50 Life Science VC Funds & Investors in Oceania (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Main Sequence Ventures
VC Fund
|
3 | Australia, United States, Philippines | Seed, Series A, Series B | Software, Artificial Intelligence, Manufacturing | $1M–$72M |
|
Powerhouse Ventures
VC Fund
|
3 | New Zealand, United States, Australia | Seed, Pre-Seed, Series A | Biotechnology, Software, Health Care | $51k–$7.9M |
|
New Zealand Green Investment Finance
VC Fund
|
3 | New Zealand, Australia, United Kingdom | Debt Financing, Seed, Venture - Series Unknown | Energy, Renewable Energy, Solar | $372k–$49M |
|
Tin Alley Ventures
VC Fund
|
2 | Australia, Philippines, United States | Pre-Seed, Seed, Series B | Biotechnology, Medical, Software | $430k–$20M |
|
AgriZeroNZ
VC Fund
|
2 | United States, New Zealand, Sweden | Seed, Series A, Venture - Series Unknown | Biotechnology, AgTech, Animal Feed | $677k–$27M |
|
Catalio Capital Management
VC Fund
|
2 | United States, Switzerland, Israel | Series A, Series B | Biotechnology, Health Care, Life Science | $9.7M–$150M |
|
Brandon Capital
VC Fund
|
2 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$81M |
|
Uniseed Ventures
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $381k–$94M |
|
Skalata
VC Fund
|
1 | Australia, United States, United Kingdom | Pre-Seed, Seed | Software, Artificial Intelligence, Information Technology | $129k–$2.3M |
|
Uniseed
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Manufacturing, Health Care | $471k–$22M |
|
ONE Innovators
VC Fund
|
1 | Japan, Australia | Series B, Seed, Series A | AgTech, Sensor, Farming | |
|
Icehouse Ventures
VC Fund
|
1 | New Zealand, United States, United Kingdom | Seed, Series A | Software, SaaS, Information Technology | $643k–$19M |
|
Breakthrough Victoria
VC Fund
|
1 | Australia, United States, Philippines | Seed, Venture - Series Unknown, Series A | Health Care, Manufacturing, Biotechnology | $500k–$35M |
|
Time Ventures
VC Fund
|
1 | United States, Canada, Germany | Series A, Series B, Seed | Software, Information Technology, Artificial Intelligence | $3.1M–$450M |
|
Fonterra Co-operative Group
VC Fund
|
1 | New Zealand, United States, Germany | Seed, Pre-Seed, Series B | Biotechnology, Food and Beverage, Wellness | $151k–$17M |
|
AbbVie Biotech Ventures
VC Fund
|
1 | United States, China, Italy | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6M–$115M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $1.3M–$35M |
|
Cure Kids Ventures
VC Fund
|
1 | New Zealand | Seed, Series A, Pre-Seed | Medical Device, Health Care, Manufacturing | $999k–$9.7M |
|
Regeneration.VC
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series A, Seed, Series B | Software, Manufacturing, Fashion | $2.1M–$30M |
|
Finistere Ventures
VC Fund
|
1 | United States, New Zealand, Israel | Series B, Series C, Series A | Biotechnology, Agriculture, Food and Beverage | $3.5M–$45M |
|
Otago Innovation
VC Fund
|
1 | New Zealand | Seed | Biotechnology, Veterinary, Life Science | $2M–$9.7M |
|
Paul Little’s family office
VC Fund
|
1 | Australia | Seed, Series A | E-Commerce, Real Estate, Life Science | |
|
Alium Capital
VC Fund
|
1 | Australia, United States, Hong Kong | Series A, Series B, Seed | Software, Artificial Intelligence, FinTech | $2M–$465M |
|
Rosrain Investments
VC Fund
|
1 | New Zealand | Series A | Life Science, Biotechnology | |
|
Massey Ventures
VC Fund
|
1 | New Zealand | Seed, Pre-Seed | Genetics, Horticulture, Life Science | |
|
Swinburne Ventures
VC Fund
|
1 | Australia | Venture - Series Unknown | Health Care, Life Science, Biotechnology | |
|
Third Hemisphere
VC Fund
|
1 | Australia | Seed | Aquaculture, Life Science, Biotechnology | |
|
Riverlane Capital
VC Fund
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Centre for Climate Action Joint Venture
VC Fund
|
1 | New Zealand | Seed | Life Science, Biotechnology | |
|
Flintco, LLC
VC Fund
|
1 | Australia | Seed | Real Estate, Life Science, Property Management | |
|
OneVentures
VC Fund
|
1 | Australia, United States, Israel | Series A, Debt Financing, Venture - Series Unknown | Software, Health Care, SaaS | $1.2M–$35M |
|
Booster
VC Fund
|
1 | New Zealand, United States | Seed, Pre-Seed, Venture - Series Unknown | Biotechnology, Manufacturing, Medical Device | $157k–$6.1M |
|
Parkview International
VC Fund
|
1 | Australia, United States | Series A, Series C | Pet, Medical, Veterinary | |
|
Antler
VC Fund
|
1 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Churchill Asset Management
VC Fund
|
1 | United States, Canada, Australia | Debt Financing, Private Equity, Series A | Health Care, Manufacturing, Food and Beverage | |
|
Possible Ventures
VC Fund
|
1 | Germany, United States, Australia | Seed, Pre-Seed, Series A | Software, Information Technology, Biotechnology | $586k–$47M |
|
Matū Group
VC Fund
|
1 | New Zealand, Australia, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Manufacturing | $337k–$25M |
|
OurCrowd
VC Fund
|
1 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $604k–$65M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $65k–$15M |
|
Digitalis Ventures
VC Fund
|
1 | United States, United Kingdom, China | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $1.5M–$132M |
|
Bioplatforms Australia
VC Fund
|
1 | Australia | Pre-Seed | AgTech, Farming, Agriculture | |
|
Callaghan Innovation
VC Fund
|
1 | New Zealand, United States, Australia | Grant, Seed, Pre-Seed | Manufacturing, Software, Information Technology | $3.5k–$1M |
|
AbbVie
VC Fund
|
1 | United States, United Kingdom, China | Series A, Grant, Seed | Biotechnology, Health Care, Medical | $3.5M–$81M |
|
HOF Capital
VC Fund
|
1 | United States, United Kingdom, Singapore | Seed, Series A, Series B | Artificial Intelligence, Software, Financial Services | $850k–$863M |
|
Herzberg Family Office
VC Fund
|
1 | Australia | Seed | Biopharma, Life Science, Therapeutics | |
|
Marex
VC Fund
|
1 | Canada, New Zealand, United States | Corporate Round, Series A | Financial Services, Finance, Lending | |
|
Cultivate Ventures
VC Fund
|
1 | New Zealand, United States | Seed, Series A | Biotechnology, Sensor, Farming | $3M–$9.6M |
|
Alberici
VC Fund
|
1 | Australia | Seed | Real Estate, Life Science, Property Management | |
|
The March Group
VC Fund
|
1 | United States, Denmark, Australia | Series A, Seed, Series C | Biotechnology, SaaS, AgTech | $4.7M–$33M |
|
Accelerating Commercialisation - AusIndustry
VC Fund
|
1 | Australia | Grant, Pre-Seed | Software, SaaS, Artificial Intelligence | $153k–$590k |
| Access all 50 VC funds in Oceania Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Manufacturing
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 134
- Round size: Seed $1M–$7M; Series A $4.8M–$30M; Series B $14M–$72M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $305M in 2023
Portfolio highlights
- Diraq — Diraq is building quantum computers using modified silicon transistors, the technology best suited to reaching utility scale, where value outweighs cost.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 23
- Round size: Seed $285k–$7.9M; Pre-Seed $51k–$373k; Series A $255k–$7M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- EdPotential — Inquire. Analyse. Act. Dedicated to improving student achievement through the power of data analytics #edtech #education
- VeriQuantix — VeriQuantix was spun out of the University of Queensland. VeriQuantix is an Australian startup specializing in cybersecurity, focusing on quantum technology to enhance the security of optical fiber communication networks. Their core innovation, Quantum Link Verification (QLV), is designed to detect and alert network operators to physical tappingattempts and intercept cyber attacks on fiber optic networks. This technology leverages quantum principles, specifically entangled photons, to verify the trustworthiness of network links by ensuring that any unauthorized access disrupts photon entanglement and triggers immediate alerts.
- Liquid Instruments — Redefining the way scientists, engineers, students, and professionals experience test and measurement with Moku software-reconfigurable hardware platforms
New Zealand Green Investment Finance provides support to the growth of innovative energy and carbon management.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Solar
- Stage:Debt Financing, Seed, Venture - Series Unknown
- Geography: New Zealand, Australia, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $3.1M–$7.6M; Debt Financing $644k–$49M; Venture - Series Unknown $372k–$3.2M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- solarZero —
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
- Far North Solar Farm — far North Solar Farm Ltd is a renewable solar energy asset developer based in Auckland. Fnsf mission is to accelerate the uptake of renewable energy in New Zealand by developing utility-scale solar assets across the country.
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Pre-Seed, Seed, Series B
- Geography: Australia, Philippines, United States
Investor stats
- Total investments: 8
- Round size: Seed $2.9M–$20M; Pre-Seed $430k–$2.9M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Mirugen — Mirugen is a preclinical biotechnology company (re)programming cells to unlock innate cellular repair mechanisms.
- Twin1 AI — Twin1 is a privacy-first platform that gives every professional an AI-powered digital twin to scale their expertise.
- Kronus — Full-stack development infrastructure for safety-critical systems.
A world-first public-private partnership helping farmers reduce emissions while maintaining profitability and productivity.
Show more...Investment focus
- Industry: Biotechnology, AgTech, Animal Feed
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, New Zealand, Sweden
Investor stats
- Total investments: 16
- Round size: Seed $677k–$10M; Series A $7M–$27M; Venture - Series Unknown $3M–$14M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Rumin8 — Rumin8 - Solving livestock methane emissions
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
- Āmua Innovation — Āmua Innovation specializes in developing solutions for pasture-based farming to lead natural food production.
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: United States, Switzerland, Israel
Investor stats
- Total investments: 144
- Round size: Series A $9.7M–$150M; Series B $26M–$130M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fresh fund, raised $16M in 2026
Portfolio highlights
- OSPRI — OSPRI is updating the infectious illness testing plan. Established by the combination of Community Direct DX, Scienetix, and the R&D section of Advanta Genetics, OSPRI is among the first molecular testing platforms in the world to be entirely vertically integrated.
- Ratio Therapeutics — Ratio is a privately held discovery-stage biotechnology company that utilizes a suite of technologies licensed from Cornell University to develop best-in-class targeted radiotherapeutics for the treatment of metastatic cancers.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 83
- Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Series B $6.4M–$68M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fresh fund, raised $290M in 2025
Portfolio highlights
- Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
- Lumonus — Hello, we are Lumonus! We empower oncology care teams through software solutions and services.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.6M; Series A $1.3M–$16M; Series B $404k–$94M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro's Wi-Fi HaLow combines long-range, strong signal penetration, low power, and high throughput in one wireless protocol, delivering connectivity to more devices, at distance, with greater reliability.
Giving Australian founders access to the education, capital and networks needed to build significant, sustainable, global businesses of the future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 92
- Round size: Seed $135k–$2.3M; Pre-Seed $129k–$406k
- Lead/follow: 80% lead, 20% follow
- Last fund: Likely still investing — raised $18M in 2021
Portfolio highlights
- Enrola — Looking for online training courses? Discover the perfect course for you with our easy course advisor quiz. Get individual guidance and apply directly.
- Paperly — Paperly helps companies streamline processes, compliance, and approvals in one platform. Gain real-time visibility and empower your teams to work with clarity and confidence.
- Cor — Obi by Cor is the leading voice AI agent for customer onboarding and user activation. It uses voice and on-screen awareness to guide users, share best practices, and answer questions in real time.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Care
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 89
- Round size: Seed $670k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $15M in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
- Facet Amtech — Facet Amtech develops and produces ammonia from water and air.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The global imperative of achieving net-zero emissions by 2050 demands innovative solutions across all nations, including Japan. Recognizing this urgency, ONE Innovators has established a dedicated venture capital fund focused on the carbon-neutral sector.
Show more...Investment focus
- Industry: AgTech, Sensor, Farming
- Stage:Series B, Seed, Series A
- Geography: Japan, Australia
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Archeda — Archeda is an IT firm that analysis of natural environments using remote sensing data.
- Creattura — Creatura assists companies in reducing greenhouse gas emissions by generating and distributing carbon credits and promoting the adoption of renewable energy sources.
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 275
- Round size: Seed $643k–$4.9M; Series A $2.5M–$19M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $318k in 2023
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 55
- Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
- Mental Jam — We are a games studio dedicated to creating impactful experiences that explore mental health.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Time Ventures is an investment fund for Marc Benioff. The company looks to invest in theB2B, hospitality, non-financial services, and commercial products and services sectors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 57
- Round size: Seed $3.1M–$450M; Series A $10M–$80M; Series B $20M–$140M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Laurel — Time by Ping frees lawyers from timekeeping so they can focus on their work, and firms can understand where time is being spent.
- June.ai — Discover June, a digital communication hub that replaces your email experience. June creates a new world for your existing email that gives you more control, interactivity and efficiency.
- June — Transform enterprise system deployment with June. AI-driven implementation for Salesforce, Snowflake, SAP & more. No downtime, faster delivery, full control.
We're a global dairy nutrition company owned by 10,000 farmers and their families, united by a fundamental belief in the power of dairy to make a difference.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Wellness
- Stage:Seed, Pre-Seed, Series B
- Geography: New Zealand, United States, Germany
Investor stats
- Total investments: 16
- Round size: Seed $581k–$724k; Pre-Seed $151k–$612k; Series B $10M–$17M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Vivici — Our mission is to meet the world's growing need for sustainable, nutritious and great tasting animal-free proteins.
- DNAiTECH — At DNAiTECH we develop innovative portable isothermal amplification instruments for point of care diagnostics, in-field applications, and rapid DNA testing.
- POP — Strengthen your dog's immunity with Pop-Topper. Developed with top animal scientists and food innovators, our formulas leverage clinically proven superfoods to reduce inflammation and promote longevity. Backed by science, our daily meal topper seamlessly integrates into your dog's routine for optimal health benefits.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, Italy
Investor stats
- Total investments: 49
- Round size: Series A $6M–$53M; Series B $12M–$83M; Series C $39M–$115M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Mozart Therapeutics — The company intended to focus on developing novel immune engagers.
- Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $1.3M–$1.7M; Series A $1.3M–$13M; Venture - Series Unknown $4.3M–$35M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics develops BEAT technology to advance CAR T-cell therapy for solid tumors, aiming to improve treatment outcomes in oncology.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood Impact investing since 2008 Portfolio Companies Invested Health Tech Products Launched Product and Service Revenue Generated Jobs Created in NZ Paediatric Patients
Show more...Investment focus
- Industry: Medical Device, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 15
- Round size: Seed $999k–$9.7M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- ISpy Nits — ISpyNits - everything you need to get rid of lice and nits once and for all
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Founded in Los Angeles, Regeneration.VC is an early-stage venture fund supercharging consumer-powered climate innovation driven by circular and regenerative principles. Our investment strategy encompasses design (materials & packaging), use (consumer brands & products), and reuse technologies (reverse logistics & marketplaces) thatgenerate measurable environmental impact alongside outsized return potential.
Show more...Investment focus
- Industry: Software, Manufacturing, Fashion
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 26
- Round size: Seed $2.1M–$17M; Series A $5.6M–$30M; Series B $18M–$23M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $45M in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- eComID — H&M-backed eComID is building the AI infrastructure to democratize personalization in commerce.
- Clarity Technology Solutions — Clarity, the category-defining item intelligence platform, provides AI-powered fraud detection technology designed to identify counterfeit, altered, and fraudulent returns and flag missing accessories at the point of return.Clarity’s technology delivers verification in just 3.2 seconds, enabling data-driven fraud detection quickly and at scale.By eliminating the need for manual inspections, associates can make confident return decisions that stop malicious activity earlier and improve both customer experience and operational efficiency.
Finistere Ventures is an agricultural technology and life sciences venture capital investor. Founded in 2005, the company partners with other entrepreneurs and creative thinkers to build innovative companies that have the potential to transform modern agriculture, increase food security, improve nutrition, and enhance sustainability. Their appliedexperience as operators, and pioneering role in Ag Tech, is actively utilized to benefit its portfolio companies and Partners. Finistere has global access to the best new technologies from centers of Ag Tech excellence in the U.S., Australia, Israel, New Zealand, and Canada through its venture partner networks. Finistere’s locations in San Diego and Palo Alto, California keeps them connected to the centers of mainstream venture investment and the world’s leading innovation ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Agriculture, Food and Beverage
- Stage:Series B, Series C, Series A
- Geography: United States, New Zealand, Israel
Investor stats
- Total investments: 70
- Round size: Series A $3.5M–$10M; Series B $5.3M–$45M; Series C $5M–$43M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $28M in 2021
Portfolio highlights
- POP — Strengthen your dog's immunity with Pop-Topper. Developed with top animal scientists and food innovators, our formulas leverage clinically proven superfoods to reduce inflammation and promote longevity. Backed by science, our daily meal topper seamlessly integrates into your dog's routine for optimal health benefits.
- Animol Discovery — Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.
- Berkeley Yeast — Better yeast for better beer. Make cleaner tasting beer with ultra low diacetyl strains, brew non alcoholic beer that tastes more like actual beer, or unlock bright grapefruit and passionfruit notes with the cleanest thiol yeast.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Otago Innovation is a research company that supports researchers from university campuses with opportunities for commercialisation.
Show more...Investment focus
- Industry: Biotechnology, Veterinary, Life Science
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 2
- Round size: Seed $2M–$9.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- InsituGen — Bioassay technology developed by InsituGen provides rapid and accurate detection of all androgenic and estrogenic activity
- Amaroq Therapeutics — Nothing remains concealed. Exploring long #noncoding #RNAs in #cancer. Founded by @oncogenie
Paul Little’s family office operates as an investment firm.
Show more...Investment focus
- Industry: E-Commerce, Real Estate, Life Science
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
- EstateXchange — Simplest way to settle deceased estates securely. Save time with estates administration. For lawyers, banks & more. Deliver faster outcomes for all.
Alium Capital focuses on listed and unlisted technology investments to generate out-sized returns. The company invests in technology, innovation, and early-stage businesses, all the way through to publicly listed assets. It specializes in the fields of finance, investing, innovation, and capital.Alium Capital was founded in 2016 andheadquartered in Sydney, New South Wales.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Series A, Series B, Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 50
- Round size: Seed $2.2M–$10M; Series A $2M–$11M; Series B $2M–$465M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $79M in 2017
Portfolio highlights
- Boost Lab — Boost Lab provides solutions for skincare products that are cost-effective, effective, and safe.
- Koala — We're simplifying the mattress and furniture game. With free & fast delivery and a 120 night risk-free trial Australia-wide, try it out online today.
- York Street Brands — York Street Brands, formed by the merger of Boost Lab and tbh Skincare specializes in serums that target a range of skin concerns.
Rosrain Investments is an investment firm.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Massey Ventures supports the development of commercially promising ideas by providing early stage investment. The firm commercializes intellectual property and innovative research. The company guides Massey researchers and students through the commercialisation process in order to make their innovative ideas a reality.
Show more...Investment focus
- Industry: Genetics, Horticulture, Life Science
- Stage:Seed, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Captivate Technology — Captivate Technology company operates a clean-tech carbon capture platform. The platform enables cement manufacturers, geothermal power plants, and biogas producers to reduce pollution and contribute to environmental initiatives by using a metal-organic framework for CO2 adsorption as a solid-state material.
- Ampersand Technologies — Ampersand Technologies, custom diagnostic insights for precision decision-making and improved outcomes. Point-of-need diagnostic testing for real-time disease detection in agriculture, horticulture, and the environment.
Swinburne Ventures operates as a venture capital firm. Swinburne Ventures the venture capital arm of Swinburne University of Technology.
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Eudaemon Technologies — The first hydrogel condom. A revolution in intimacy.
Third Hemisphere is a technology and finance communications firm for innovators and leaders who are breaking new ground.
Show more...Investment focus
- Industry: Aquaculture, Life Science, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Fremantle Seaweed — Fremantle Seaweed is committed to combating climate change by growing Asparagopsis along with a variety of other local seaweeds ocean grown in local Western Australia waters.
Long-term owner-operators of great Australian businesses.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Centre for Climate Action Joint Venture focuses on investment and effort in tackling New Zealand’s Agricultural emissions to meet reduction targets
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Flintco provides innovative construction solutions with an unrelenting focus on quality, safety, cost and schedule.
Show more...Investment focus
- Industry: Real Estate, Life Science, Property Management
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LCG Capital Management — LCG Capital Management is a full-service commercial real estate firm providing integrated solutions across the real estate lifecycle.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Series A, Debt Financing, Venture - Series Unknown
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 87
- Round size: Series A $1.5M–$23M; Debt Financing $1.2M–$14M; Venture - Series Unknown $4M–$35M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely actively investing — fresh fund, raised $126M in 2025
Portfolio highlights
- me&u — me&u is an online ordering and payment application designed to order meals. They provide communication technology to order and pay through mobile phones at restaurants. Their process of ordering with waiters and splitting bills that enable users to order their food and pay bills through a digital payment platform.
- Truescope — Make better informed communications decisions with Truescope. Harnessing millions of media posts every day to deliver you real-time information that influences your business strategy.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Booster is an investment manager, superannuation and default KiwiSaver scheme provider. We offer ethical, New Zealand and specialist investment options.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United States
Investor stats
- Total investments: 21
- Round size: Seed $715k–$4.3M; Pre-Seed $157k–$972k; Venture - Series Unknown $158k–$6.1M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Linca — Critical metals for a circular battery supply chain
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Wych Limited — Wych puts your financial health back in your control.
Parkview International operates as a single-family office.
Show more...Investment focus
- Industry: Pet, Medical, Veterinary
- Stage:Series A, Series C
- Geography: Australia, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Petfolk — Petfolk's world-class animal hospitals & pet care centers offer virtual, in-person & urgent veterinary care with a pet-parent-focused approach. Learn more!
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 2372
- Round size: Seed $158k–$4.5M; Pre-Seed $100k–$587k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
- Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
- RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
Churchill Asset Management provides private credit and private equity solutions for PE-backed middle market companies across the full capital structure.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Food and Beverage
- Stage:Debt Financing, Private Equity, Series A
- Geography: United States, Canada, Australia
Investor stats
- Total investments: 34
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely actively investing — fresh fund, raised $1.5M in 2026
Portfolio highlights
- US Fertility — US Fertility brings together the brightest minds in reproductive medicine to achieve the highest clinical standards and pregnancy rates in the country. Discover excellence in fertility care today.
- One Physics — Apex Physics Partners serves medical centers and physics practices by offering therapy and diagnostic services and support for medical physics practices.
- Action Behavior Centers — Action Behavior Centers is a center-based provider of ABA therapy for children on the moderate to severe end of the autism spectrum.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United States, Australia
Investor stats
- Total investments: 172
- Round size: Seed $1.5M–$10M; Pre-Seed $586k–$3.5M; Series A $9.7M–$47M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Mkind — Mkind builds intelligent robots for high-mix manufacturing, developing advanced automation solutions that can adapt to diverse production requirements, improve operational efficiency, and support manufacturers in handling complex, low-volume, and frequently changing product lines.
- Orbem — Transform biological imaging with AI-powered MRI technology. Non-invasive solutions for poultry, fruits, nuts, and health. Building a sustainable future.
- Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 22
- Round size: Seed $473k–$4.6M; Pre-Seed $337k–$972k; Series A $2.3M–$25M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Advemto — Advemto is the manufacturer and developer of ultrafast spectroscopy systems that help researchers.
- Inhibit Coatings — Inhibit Coatings is a New Zealand based company developing novel antimicrobial and antifouling coatings.
- Captivate Technology — Captivate Technology company operates a clean-tech carbon capture platform. The platform enables cement manufacturers, geothermal power plants, and biogas producers to reduce pollution and contribute to environmental initiatives by using a metal-organic framework for CO2 adsorption as a solid-state material.
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 363
- Round size: Seed $604k–$9.5M; Series A $4.5M–$22M; Series B $7M–$65M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely actively investing — fresh fund, raised $230k in 2026
Portfolio highlights
- N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
- MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 619
- Round size: Seed $65k–$4.6M; Pre-Seed $70k–$553k; Series A $2.3M–$15M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $36M in 2023
Portfolio highlights
- CUZIN — CUZIN is your global shopping family. A community marketplace enabling members to purchase any product worldwide by leveraging other members’ buying access or advantages.Members post requests for any product they want from anywhere in the world. Online or offline, specialist boutiques/clearance outlets and sales. This request is pushed to'cuzins' best placed (geographically or commercially) to purchase the item on their behalf. Cuzins earn a tip for helping out!In addition to accepting a shopping request, any cuzin can instantly monetise being in the right place at the right time posting a purchase opportunity, which is pushed to interested members worldwide. Shopping, shipping, social. Sorted. CUZIN provides the social and logistics platform to facilitate the matching, communication, payment and shipping of the items we love worldwide.
- Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Engineering solutions to complex problems in health through venture investment and company creation.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 117
- Round size: Seed $1.5M–$15M; Series A $7.5M–$66M; Series B $13M–$132M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $300M in 2023
Portfolio highlights
- Neion Bio — We convert nature's best molecular factories into the biomanufacturing platform of the future.
- Omni — Omni provides Healthy Vegan Dog Food in the UK, made by vets to be a nutritionally complete meal for your dog. Feed your dog all the goodness of plants backed by science.
- Buddy Bites — Subscription pet food delivered straight to your door! Convenient & healthy pet food approved by vets. Made in Europe with premium quality. 2kg to you, 1kg donated to Hong Kong pet shelters.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bioplatforms Australia is a non-profit entity that supports life science research in genomic, proteomics, metabolomics, and bioinformatics.
Show more...Investment focus
- Industry: AgTech, Farming, Agriculture
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
Callaghan Innovation is a stand-alone Crown Entity established on 1 February, 2013. Their role hasn’t previously existed in New Zealand.When they succeed, all New Zealanders will benefit from a stronger economy, higher value exports, more productive and sustainable resource use, more jobs and higher incomes.International evidence showsadvanced technology institutes like Callaghan Innovation have been successful at helping businesses build innovation capability that contributes to their growth and the broader economy.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Grant, Seed, Pre-Seed
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 3147
- Round size: Seed $351k–$1M; Grant $3.5k–$135k; Pre-Seed $607k–$716k
- Lead/follow: 99% lead, 1% follow
Portfolio highlights
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
- Sterling — Sterling operates an artificial intelligence platform designed to automate back-office operations for financial and accounting teams. The software deploys deterministic AI agents that execute repetitive tasks like accounts payable, accounts receivable, compliance checks, and bank reconciliations directly inside existing enterprise applications. Byfunctioning as a background virtual assistant, its value proposition centers on eliminating administrative bottlenecks while maintaining strict human-in-the-loop oversight and enterprise-grade audit standards.
- Forever Harvest — We are an Aotearoa New Zealand based cellular horticulture company, partnering with food & beverage manufacturers to develop new fruit & nut food solutions.
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Grant, Seed
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 65
- Round size: Seed $4M–$42M; Grant $3.5M–$50M; Series A $7M–$81M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
- Endlyz Therapeutics — ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
HOF Capital is a global technology investment firm that leverages its global limited partner network to help founders build massive businesses.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 236
- Round size: Seed $850k–$14M; Series A $10M–$40M; Series B $20M–$863M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Jota — Jota: The platform handles finances for individual entrepreneurs and business owners by allowing them to instantly pay, collect receivables, and manage their day-to-day operations with voice notes, text messages, and images through an AI-first chat conversation. All tasks are free and executed in seconds. Designed to save time and money, Jotaempowers its clients to focus on what truly matters to them.
- Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
- Valar Atomics — Valar Atomics is scaling nuclear energy for heavy industrial power and clean hydrocarbon fuel production.
Family Office
Show more...Investment focus
- Industry: Biopharma, Life Science, Therapeutics
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Mucpharm — Clinical stage bio-pharma company focused on the treatment of mucin-containing and secreting cancers. Bromelain and acetylcysteine, BromAc™, is a patented combination drug developed by our team for mucinous cancers, where the drug affects glycosidic linkages and disulphide bonds in glycoproteins including mucinous tumours. Bromelain is an enzymeextracted from pineapple stem or fruit (ananas comosus) and it is made up of a number of enzymes (proteases, carbohydrases, phosphatases, peroxidases, etc.) that gives it unique enzymatic properties for the hydrolysis of glycosidic bonds in complex carbohydrates. As a therapeutic molecule, it is currently used as a mucolytic in combination with acetylcysteine with anticancer properties for the treatment of mucinous tumours. It combines synergistically with a variety of anticancer drugs.
Marex.com is a provider of business-to-business e-commerce solutions for the marine industry offers a proprietary set of procurement solutions.
Show more...Investment focus
- Industry: Financial Services, Finance, Lending
- Stage:Corporate Round, Series A
- Geography: Canada, New Zealand, United States
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
- Key Carbon — Carbon Neutral Royalty operates a permanent capital vehicle designed to finance projects in the Voluntary Carbon Markets (VCM) through a prepayment in exchange for a portion of future carbon credits. The company specializes in financial support for the project and sells carbon credits to corporations that have made net zero pledges to help themmeet their climate, biodiversity, and community commitments.Carbon Neutral Royalty was established in July, 2021 in Vancouver, British Columbia.
- Digital Prime Technologies — Full-Service Institutional-Grade Prime Brokerage for Digital Asset Management. DLCC offers full-service Prime Brokerage solutions for digital assets. Our all-in-one user interface leverages both API and Saas product offerings to connect clients with a growing network of liquidity providers to transact, borrow, and lend digital assets, and managecollateral. Our product suite also offers traditional Prime Brokerage services, such as consultation and capital introduction.
Cultivate Ventures is an investment and advisory firm built to catalyze growth for promising food, wellness and fitness companies. We focus specifically on investment, business concept incubation, seed-to-growth stage acceleration and turn around advisory services. We believe strongly in strong returns on capital combined with collaboration,transparency, conscious consumerism. We take a long-term, collaborative and flexible approach to each company and client we work with and invest in, allowing our financial and operational stake to grow as our partners grow.
Show more...Investment focus
- Industry: Biotechnology, Sensor, Farming
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 5
- Round size: Seed $3M–$7M; Series A $7.3M–$9.6M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Hectre — Award winning, simple to use orchard apps for performance and cost management optimization.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Alberici is a diversified construction company recognized for superior quality and customer service. With operations throughout North America and clients around the world, they offer general contracting, construction management, and design-build solutions across a broad spectrum of industrial and commercial markets.
Show more...Investment focus
- Industry: Real Estate, Life Science, Property Management
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- LCG Capital Management — LCG Capital Management is a full-service commercial real estate firm providing integrated solutions across the real estate lifecycle.
A venture capital fund platform committed to supporting and investing in entrepreneurs and companies developing and bringing exponential technologies to food, health and sustainability. March's investment strategy involves becoming recognized as the leading investor in critical and transformative technology solutions, and aims to achieve thisby investing into companies and funds that focus on developing core intellectual property around game-changing sustainable solutions that are aligned with globally relevant sustainability trends and benefits.
Show more...Investment focus
- Industry: Biotechnology, SaaS, AgTech
- Stage:Series A, Seed, Series C
- Geography: United States, Denmark, Australia
Investor stats
- Total investments: 7
- Round size: Seed $4.7M–$4.8M; Series A $7.2M–$33M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $5.5M in 2026
Portfolio highlights
- Digestiva — We amplifye Protein.
- EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
A grant program offered by AusIndustry as part of the Australian Government’s National Innovation and Science Agenda
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Grant, Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 10
- Round size: Grant $153k–$590k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Getmee — Getmee AI is the leading AI-powered coaching app for communication and employability. We help you improve your English, soft skills, and interview confidence!
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Oceania Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!